Macaulay Onuigbo

All-cause costs increase exponentially with increased chronic kidney disease stage.

Ladan Golestaneh, Paula J. Alvarez, Nancy L. Reaven et al. · PubMed · 2017 · 137 citations

Medicine, Nephrology, Pharmacoeconomics +17

High Population Frequencies of APOL1 Risk Variants Are Associated with Increased Prevalence of Non-Diabetic Chronic Kidney Disease in the Igbo People from South-Eastern Nigeria

Ifeoma Ulasi, Shay Tzur, Walter G. Wasser et al. · Nephron Clinical Practice · 2013 · 110 citations

Medicine, Genetics, Nephrology +15

Echocardiography Criteria for Structural Heart Disease in Patients With End-Stage Renal Disease Initiating Hemodialysis

LaTonya J. Hickson, Sara Negrotto, Macaulay Onuigbo et al. · Journal of the American College of Cardiology · 2016 · 93 citations · Full text

Medicine, Cardiology, Nephrology +16

End of Life, Withdrawal, and Palliative Care Utilization among Patients Receiving Maintenance Hemodialysis Therapy

Bjorg Thorsteinsdottir, Lisa E. Vaughan, Molly A. Feely et al. · Clinical Journal of the American Society of Nephrology · 2018 · 59 citations · Full text

Medicine, Nephrology, End-of-life Care +13

Late-onset renal failure from angiotensin blockade (LORFFAB) in 100 CKD patients

Macaulay Onuigbo, Nnonyelum T.C. Onuigbo · International Urology and Nephrology · 2008 · 58 citations

Medicine, Nephrology, Pharmacotherapy +13